Fetal care study for babies with slow growth
Part of Genetic & congenital, Women’s health & pregnancy clinical trials.
This study looks at therapies meant to support brain development in babies whose growth is slower than expected before birth. It enrolls pregnancies in a specific time window and uses ultrasound/Doppler testing to make sure the baby is not likely needing delivery immediately.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are pregnant with one baby (singleton pregnancy), not twins or more
- Ultrasound shows the baby has no major birth defects (no structural problems)
- Your pregnancy is in the fetal growth restriction category (baby is growing too slowly)
- You are between 24 weeks and 32 weeks plus 6 days pregnant when joining
- No signs of serious blood-flow concern that suggest delivery is needed within 14 days (based on Doppler tests)
- The mother does not have a major mental health or psychiatric condition, and is not allergic to cow’s milk protein
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at how to diagnose and manage pregnancies and babies affected by slow growth before birth, birth defects, or chromosome-related conditions. It may help by improving how doctors confirm problems and plan care for mothers and newborns.
This study looks at babies in monochorionic (shared-placenta) twin pregnancies where one or both babies are growing too slowly. It aims to better understand this condition and follow families over time to improve care, with check-ins through age 2 after birth.
This study looks at two ways to manage early-onset fetal growth restriction (when a baby is smaller than expected). It compares using blood tests for angiogenic factors versus feto-placental Doppler ultrasound to guide care. The goal is to find the best way to monitor and protect your baby's health.
This study tests whether a blood-thinner medicine (LMWH) can improve outcomes for people carrying a singleton baby with early signs of slow growth. It compares LMWH against standard care to see if treatment helps the baby and pregnancy stay safer.
This trial studies whether taking melatonin during pregnancy can help protect the baby’s brain and organs in cases of poor fetal growth. It focuses on pregnancies at a specific gestational age with signs that the placenta may not be working well.
This study compares a computer-based analysis of the baby's heart rate tracing (called STV) with the standard visual check doctors perform. The goal is to see if the computer method better identifies babies who are struggling, so doctors can act sooner to keep the baby safe.
Hear when a new Fetal Growth Retardation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.